focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,756.00
Bid: 1,753.00
Ask: 1,754.00
Change: -19.00 (-1.07%)
Spread: 1.00 (0.057%)
Open: 1,770.00
High: 1,770.00
Low: 1,740.00
Prev. Close: 1,775.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BROKER RATINGS SUMMARY: UBS Cuts GlaxoSmithKline To Neutral From Buy

Thu, 14th May 2015 08:38

LONDON (Alliance News) - The following shares received analyst recommendations Thursday morning and Wednesday afternoon:
----------
FTSE 100
----------
UBS CUTS GLAXOSMITHKLINE TO 'NEUTRAL' ('BUY') - PRICE TARGET 1500 (1700) PENCE
----------
NUMIS CUTS EASYJET TO 'ADD' ('BUY') - TARGET 1850 (2100) PENCE
----------
NUMIS RAISES JOHNSON MATTHEY PRICE TARGET TO 3780 (3642) PENCE - 'ADD'
----------
TRADERS: JEFFERIES INITIATES CENTRICA WITH 'BUY'
----------
BERNSTEIN CUTS AB FOODS PRICE TARGET TO 2800 (3000) PENCE - 'MARKET-PERFORM'
----------
NOMURA RAISES SABMILLER PRICE TARGET TO 3600 (3400) PENCE - 'NEUTRAL'
----------
DEUTSCHE BANK RAISES MONDI PLC PRICE TARGET TO 1640 (1510) PENCE - 'BUY'
----------
LIBERUM RAISES BARRATT DEVELOPMENTS PRICE TARGET TO 536 (519) PENCE - 'HOLD'
----------
Numis Cuts ITV To Add From Buy, Price Target Raised To 290p From 275p
----------
FTSE 250
----------
NUMIS RAISES ZOOPLA PROPERTY PRICE TARGET TO 245 (215) PENCE - 'ADD'
----------
JPMORGAN CUTS JOHN WOOD PRICE TARGET TO 497 (505) PENCE - 'UNDERWEIGHT'
----------
UBS RAISES PARAGON GROUP PRICE TARGET TO 512 (450) PENCE - 'BUY'
----------
BERENBERG RAISES HOWDEN JOINERY GROUP PRICE TARGET TO 530 (525) PENCE - 'BUY'
----------
MAIN MARKET AND AIM
----------
NUMIS CUTS CHIME COMMUNICATIONS TO 'ADD' ('BUY') - TARGET 339 (400) PENCE
----------
NUMIS RAISES CENTAUR MEDIA PRICE TARGET TO 90 (84) PENCE - 'BUY'
----------
UBS CUTS OXFORD INSTRUMENTS TO 'NEUTRAL' ('BUY') - TARGET 1150 (950) PENCE
----------
Liberum Raises NewRiver Retail Price Target To 355p From 336p, Reiterates Buy
----------
Cantor Fitzgerald Upgrades Greenko Group To Buy From Hold, Price Target Cut To 82p From 86p
----------
PANMURE INITIATES XP POWER WITH 'BUY' - TARGET 1709 PENCE
----------
By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun

Copyright 2015 Alliance News Limited. All Rights Reserved.

More News
1 Feb 2024 09:27

TOP NEWS: GSK maintains "vigorous" defence after settling Zantac case

(Alliance News) - GSK PLC on Thursday insisted upon its scientific integrity, after reaching another settlement in ongoing litigation over alleged links between its heartburn drug and cancer.

Read more
1 Feb 2024 09:11

GSK settles Zantac case in California without admitting liability

(Sharecast News) - GSK announced on Thursday that it had reached a confidential settlement to effectively resolve the legal case over Zantac filed in a California state court.

Read more
1 Feb 2024 09:03

LONDON BROKER RATINGS: Barclays cuts Next; JPMorgan raises easyJet

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
1 Feb 2024 07:42

LONDON BRIEFING: Shell profit falls; announces USD3.5 billion buyback

(Alliance News) - Stocks in London are set to follow New York into the red, after the US Federal Reserve quashed hopes of a March cut to interest rates and ahead of the Bank of England interest rate decision.

Read more
31 Jan 2024 17:05

LONDON MARKET CLOSE: Stocks mixed hours before expected US Fed hold

(Alliance News) - Stock prices in London closed mixed on Wednesday in a trade-thinned day ahead of the US Federal Reserve interest rate decision this evening.

Read more
31 Jan 2024 15:49

London close: Stocks mixed ahead of US Fed, BoE decisions

(Sharecast News) - London's financial markets finished with mixed performance on Wednesday, with investors closing their wallets ahead of rate announcements from both the US Federal Reserve and the Bank of England.

Read more
31 Jan 2024 12:05

LONDON MARKET MIDDAY: FTSE 100 flat ahead of Federal Reserve decision

(Alliance News) - The FTSE 100 in London was flat heading into Wednesday afternoon, as the US Federal Reserve's latest interest rate decision edges closer, keeping equity market enthusiasm to a minimum.

Read more
31 Jan 2024 09:13

TOP NEWS: GSK profit up on Arexvy boost in 2023 but total payout down

(Alliance News) - GSK PLC reported an increase in profit and revenue for 2023 as revenue for HIV medicine had stable growth, amid optimism in the company's outlook.

Read more
31 Jan 2024 08:55

LONDON MARKET OPEN: Stocks lack direction ahead of Fed, BoE

(Alliance News) - Stock prices in London lacked direction at the open on Wednesday, as investors nervously look ahead to interest rate decisions from the US Federal Reserve and Bank of England.

Read more
31 Jan 2024 07:46

LONDON BRIEFING: Stocks called up; GSK revenue and profit up

(Alliance News) - Stocks in London are called to open higher, as markets share of nerves around the next set of interest rate decisions.

Read more
29 Jan 2024 08:51

GSK seeks expanded use of RSV vaccine in EU, wins approval for Omjjara

(Alliance News) - GSK PLC on Monday celebrated regulatory progress for two of its products in the EU.

Read more
29 Jan 2024 07:43

LONDON BRIEFING: Superdry looks at saving costs; Ferrexpo loses case

(Alliance News) - Stocks in London are expected to start the week on a cautious note, as investors nervously look ahead to two key interest rate decisions.

Read more
29 Jan 2024 07:07

GSK gets EU approval to sell blood cancer treatment Omijara

(Sharecast News) - Biopharma giant GSK has been given the green light by European regulators to sell Omjjara, its treatment for patients with a rare type of blood cancer.

Read more
26 Jan 2024 10:47

Citi hikes target price for GSK but stays 'neutral'

(Sharecast News) - Shares in biopharma giant GSK were rising on Friday, helped by forecast upgrades from Citi, which raised its target price on the stock from 1,535p to 1,700p.

Read more
24 Jan 2024 15:08

Private equity firm Yellow Wood close to deal to acquire ChapStick-sources

Jan 24 (Reuters) - Private equity firm Yellow Wood Partners is in advanced talks to acquire ChapStick, a lip balm brand, from Haleon Plc, the former consumer health division of drug developer GSK Plc, four people familiar with the matter said.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.